rdf:type |
|
lifeskim:mentions |
umls-concept:C0031715,
umls-concept:C0031727,
umls-concept:C0035679,
umls-concept:C0109317,
umls-concept:C0752312,
umls-concept:C1150579,
umls-concept:C1314939,
umls-concept:C1333340,
umls-concept:C1334474,
umls-concept:C1335071,
umls-concept:C1366882,
umls-concept:C1370600,
umls-concept:C1442905,
umls-concept:C1514562,
umls-concept:C1705767,
umls-concept:C1705791,
umls-concept:C1707271,
umls-concept:C1880389,
umls-concept:C1883204,
umls-concept:C1883221
|
pubmed:issue |
22
|
pubmed:dateCreated |
1999-12-28
|
pubmed:abstractText |
The largest subunit of the mammalian RNA polymerase II possesses a C-terminal domain (CTD) consisting of 52 repeats of the consensus sequence, Tyr(1)-Ser(2)-Pro(3)-Thr(4)-Ser(5)-Pro(6)-Ser(7). Phosphorylation of the CTD is known to play a key role in gene expression. We now show that treatments such as osmotic and oxidative shocks or serum stimulation generate a new type of phosphorylated subunit, the IIm form. This IIm form might be generated in vivo by ERK-type MAP kinase phosphorylation as: (i) ERK1/2 are major CTD kinases found in cell extracts; (ii) the immunoreactivity of the IIm form against a panel of monoclonal antibodies indicates that the CTD is exclusively phosphorylated on Ser-5 in the repeats, like RNA polymerase II phosphorylated in vitro by an ERK1/2; and (iii) the IIm form does not appear when ERK activation is prevented by treating cells with low concentrations of highly specific inhibitors of MEK1/2. Since the IIm subunit is not affected by inhibition of transcription and is not bound to chromatin, it does not participate in transcription.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antibodies, Monoclonal,
http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors,
http://linkedlifedata.com/resource/pubmed/chemical/MAP Kinase Kinase 1,
http://linkedlifedata.com/resource/pubmed/chemical/MAP Kinase Kinase 2,
http://linkedlifedata.com/resource/pubmed/chemical/Map2k1 protein, mouse,
http://linkedlifedata.com/resource/pubmed/chemical/Mitogen-Activated Protein Kinase...,
http://linkedlifedata.com/resource/pubmed/chemical/Protein-Serine-Threonine Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/Protein-Tyrosine Kinases,
http://linkedlifedata.com/resource/pubmed/chemical/RNA Polymerase II
|
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
1362-4962
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4399-404
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:10536148-3T3 Cells,
pubmed-meshheading:10536148-Animals,
pubmed-meshheading:10536148-Antibodies, Monoclonal,
pubmed-meshheading:10536148-Enzyme Inhibitors,
pubmed-meshheading:10536148-Gene Expression Regulation,
pubmed-meshheading:10536148-MAP Kinase Kinase 1,
pubmed-meshheading:10536148-MAP Kinase Kinase 2,
pubmed-meshheading:10536148-Mice,
pubmed-meshheading:10536148-Mitogen-Activated Protein Kinase Kinases,
pubmed-meshheading:10536148-Osmotic Pressure,
pubmed-meshheading:10536148-Phosphorylation,
pubmed-meshheading:10536148-Protein-Serine-Threonine Kinases,
pubmed-meshheading:10536148-Protein-Tyrosine Kinases,
pubmed-meshheading:10536148-RNA Polymerase II,
pubmed-meshheading:10536148-Transcription, Genetic
|
pubmed:year |
1999
|
pubmed:articleTitle |
Transcription-independent phosphorylation of the RNA polymerase II C-terminal domain (CTD) involves ERK kinases (MEK1/2).
|
pubmed:affiliation |
Laboratoire de Régulation de l'Expression Génétique, CNRS UMR 8541, Ecole Normale Supérieure, 46 rue d'Ulm, 75230 Paris Cedex 05, France.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|